151 related articles for article (PubMed ID: 31998567)
21. Nuclear import of adenovirus DNA involves direct interaction of hexon with an N-terminal domain of the nucleoporin Nup214.
Cassany A; Ragues J; Guan T; Bégu D; Wodrich H; Kann M; Nemerow GR; Gerace L
J Virol; 2015 Feb; 89(3):1719-30. PubMed ID: 25410864
[TBL] [Abstract][Full Text] [Related]
22. Selective Removal of FG Repeat Domains from the Nuclear Pore Complex by Enterovirus 2A(pro).
Park N; Schweers NJ; Gustin KE
J Virol; 2015 Nov; 89(21):11069-79. PubMed ID: 26311873
[TBL] [Abstract][Full Text] [Related]
23. Peptide mimotopes selected with HIV-1-blocking monoclonal antibodies against CCR5 represent motifs specific for HIV-1 entry.
Königs C; Pustowka A; Irving J; Kessel C; Klich K; Wegner V; Rowley MJ; Mackay IR; Kreuz W; Griesinger C; Dietrich U
Immunol Cell Biol; 2007 Oct; 85(7):511-7. PubMed ID: 17607321
[TBL] [Abstract][Full Text] [Related]
24. The nuclear pore complex: a new dynamic in HIV-1 replication.
Woodward CL; Chow SA
Nucleus; 2010; 1(1):18-22. PubMed ID: 21327100
[TBL] [Abstract][Full Text] [Related]
25. Characterization of Human Immunodeficiency Virus (HIV-1) Envelope Glycoprotein Variants Selected for Resistance to a CD4-Mimetic Compound.
Anang S; Richard J; Bourassa C; Goyette G; Chiu TJ; Chen HC; Smith AB; Madani N; Finzi A; Sodroski J
J Virol; 2022 Sep; 96(17):e0063622. PubMed ID: 35980207
[TBL] [Abstract][Full Text] [Related]
26. Binding thermodynamics of the N-terminal peptide of the CCR5 coreceptor to HIV-1 envelope glycoprotein gp120.
Brower ET; Schön A; Klein JC; Freire E
Biochemistry; 2009 Feb; 48(4):779-85. PubMed ID: 19170639
[TBL] [Abstract][Full Text] [Related]
27. Electrostatic modeling of peptides derived from the V3-loop of HIV-1 gp120: implications of the interaction with chemokine receptor CCR5.
Morikis D; Rizos AK; Spandidos DA; Krambovitis E
Int J Mol Med; 2007 Mar; 19(3):343-51. PubMed ID: 17273779
[TBL] [Abstract][Full Text] [Related]
28. Defining the HIV Capsid Binding Site of Nucleoporin 153.
Li S; Patel JS; Yang J; Crabtree AM; Rubenstein BM; Lund-Andersen PK; Ytreberg FM; Rowley PA
mSphere; 2022 Oct; 7(5):e0031022. PubMed ID: 36040047
[TBL] [Abstract][Full Text] [Related]
29. Structure of the cytoplasmic ring of the
Zhu X; Huang G; Zeng C; Zhan X; Liang K; Xu Q; Zhao Y; Wang P; Wang Q; Zhou Q; Tao Q; Liu M; Lei J; Yan C; Shi Y
Science; 2022 Jun; 376(6598):eabl8280. PubMed ID: 35679404
[TBL] [Abstract][Full Text] [Related]
30. Protein promiscuity: drug resistance and native functions--HIV-1 case.
Fernández A; Tawfik DS; Berkhout B; Sanders R; Kloczkowski A; Sen T; Jernigan B
J Biomol Struct Dyn; 2005 Jun; 22(6):615-24. PubMed ID: 15842167
[TBL] [Abstract][Full Text] [Related]
31. Kinetic factors control efficiencies of cell entry, efficacies of entry inhibitors, and mechanisms of adaptation of human immunodeficiency virus.
Platt EJ; Durnin JP; Kabat D
J Virol; 2005 Apr; 79(7):4347-56. PubMed ID: 15767435
[TBL] [Abstract][Full Text] [Related]
32. Residues in the gp41 Ectodomain Regulate HIV-1 Envelope Glycoprotein Conformational Transitions Induced by gp120-Directed Inhibitors.
Pacheco B; Alsahafi N; Debbeche O; Prévost J; Ding S; Chapleau JP; Herschhorn A; Madani N; Princiotto A; Melillo B; Gu C; Zeng X; Mao Y; Smith AB; Sodroski J; Finzi A
J Virol; 2017 Mar; 91(5):. PubMed ID: 28003492
[TBL] [Abstract][Full Text] [Related]
33. Molecular modeling on human CCR5 receptors and complex with CD4 antigens and HIV-1 envelope glycoprotein gp120.
Yang J; Liu CQ
Acta Pharmacol Sin; 2000 Jan; 21(1):29-34. PubMed ID: 11263244
[TBL] [Abstract][Full Text] [Related]
34. HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded.
Quitadamo B; Peters PJ; Repik A; O'Connell O; Mou Z; Koch M; Somasundaran M; Brody R; Luzuriaga K; Wallace A; Wang S; Lu S; McCauley S; Luban J; Duenas-Decamp M; Gonzalez-Perez MP; Clapham PR
J Virol; 2018 Jan; 92(2):. PubMed ID: 29118121
[TBL] [Abstract][Full Text] [Related]
35. The role of the N-terminal segment of CCR5 in HIV-1 Env-mediated membrane fusion and the mechanism of virus adaptation to CCR5 lacking this segment.
Melikyan GB; Platt EJ; Kabat D
Retrovirology; 2007 Aug; 4():55. PubMed ID: 17686153
[TBL] [Abstract][Full Text] [Related]
36. Effects of ELF magnetic field in combination with Iron(III) chloride (FeCl3) on cellular growth and surface morphology of Escherichia coli (E. coli).
Esmekaya MA; Acar SI; Kıran F; Canseven AG; Osmanagaoglu O; Seyhan N
Appl Biochem Biotechnol; 2013 Apr; 169(8):2341-9. PubMed ID: 23446980
[TBL] [Abstract][Full Text] [Related]
37. A role for microRNA-155 modulation in the anti-HIV-1 effects of Toll-like receptor 3 stimulation in macrophages.
Swaminathan G; Rossi F; Sierra LJ; Gupta A; Navas-Martín S; Martín-García J
PLoS Pathog; 2012 Sep; 8(9):e1002937. PubMed ID: 23028330
[TBL] [Abstract][Full Text] [Related]
38. Human immunodeficiency virus and host cell lipids. Interesting pathways in research for a new HIV therapy.
Raulin J
Prog Lipid Res; 2002 Jan; 41(1):27-65. PubMed ID: 11694268
[TBL] [Abstract][Full Text] [Related]
39. Structural and functional characterization of the human CCR5 receptor in complex with HIV gp120 envelope glycoprotein and CD4 receptor by molecular modeling studies.
Liu S; Fan S; Sun Z
J Mol Model; 2003 Oct; 9(5):329-36. PubMed ID: 14517611
[TBL] [Abstract][Full Text] [Related]
40. Extremely low frequency (ELF) stray magnetic fields of laboratory equipment: a possible co-exposure conducting experiments on cell cultures.
Gresits I; Necz PP; Jánossy G; Thuróczy G
Electromagn Biol Med; 2015 Sep; 34(3):244-50. PubMed ID: 26444200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
